# Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia

> **NCT05259228** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Tyrosine Kinase Inhibitor
- Pharmacokinetics
- Therapeutic Drug Monitoring

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05259228
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259228, "Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05259228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*